Walkers Acts for Pfizer in US$11.6 Billion Acquisition of Biohaven Pharmaceuticals

Walkers is pleased to have acted as British Virgin Islands counsel to Pfizer Inc. on its proposed US$11.6 billion acquisition of NYSE listed Biohaven Pharmaceutical. The take-private transaction will be implemented by way a BVI statutory merger and would represent the largest ever takeover of a publicly-listed BVI company by transaction value. The transaction underscores Walkers' leading M&A practice in the BVI.

Commenting on the transaction, BVI Managing Partner Matthew Cowman said, "We are delighted to have worked alongside Ropes & Gray on such an important transaction for Pfizer. Transactions like this demonstrate the attractiveness of the BVI as a jurisdiction that can facilitate complex cross-border M&A deals for listed clients".

The Walkers team of Matthew Cowman and Alex Drysdale advised Pfizer on the transaction alongside US counsel Ropes & Gray.

Matthew Cowman Managing PartnerT +1 284 852 2208matthew.cowman@walkersglobal.com
Alex DrysdalePartnerT +1 284 852 2262 alex.drysdale@walkersglobal.com

Related Content